Crossmark

Circulating biomarkers of extracellular matrix dysregulation are associated with adverse post-stage 2 outcomes in infants with single ventricle heart disease

Crossref DOI link: https://doi.org/10.1038/s41598-023-43562-4

Published Online: 2023-09-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Frank, Benjamin S.

Nandy, Debmalya

Khailova, Ludmila

Mitchell, Max B.

Morgan, Gareth J.

Twite, Mark

DiMaria, Michael V.

Davidson, Jesse A.
Funding

Funding for this research was provided by:

American Heart Association (20CDA35310498, 18IPA34170070)

National Heart, Lung, and Blood Institute (K23HL163490, K23HL123634)

Jayden DeLuca Foundation

Additional Ventures
License Information

Text and Data Mining valid from 2023-09-28

Version of Record valid from 2023-09-28
More Information

Article History

Received: 14 June 2023

Accepted: 26 September 2023

First Online: 28 September 2023

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below